REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Biomed (Indonesia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: PT Biomed Profile Updated: February 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Biomed is a company based in Indonesia, with its head office in Central Jakarta. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on September 11, 2002. The company’s latest financial report indicates a net sales revenue increase of 12.87% in 2022. There was a total growth of 14.19% in PT Biomed’s total assets over the same period.

Headquarters
Jl. Palmerah Utara No. 61A RT. 001 RW. 001
Central Jakarta; Jakarta; Postal Code: 10270

Contact Details: Purchase the PT Biomed report to view the information.

Website: http://www.appeton.co.id

Basic Information
Outstanding Shares:
Purchase the PT Biomed report to view the information.
Registered Capital:
Purchase the PT Biomed report to view the information.
Incorporation Date:
September 11, 2002
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Biomed report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
12.87%
Total operating revenue
12.87%
Total assets
14.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?